[FURL=https://www.industryarc.com/Research/Prostate-Biopsy-Market-Research-507068?utm_source=briefingwire&utm_medium=pressrelease&utm_campaign=paidpressrelease]Prostate Biopsy Market[/FURL] size is estimated to reach $6,650 million by 2026, after growing at a CAGR of 11% during the forecast period 2021-2026. Prostate biopsy is used for the treatment of prostate cancer which is ideal to collect sample tissue from prostate to identify cancer. The prostate specific antigen test (PSA Test) is used in screening prostate cancer and helps to determine the necessity for prostate biopsy. With the help of biopsy procedure, small sample of prostate are removed to verify the presence of cancer. A prostate biopsy uses transrectal ultrasound which is used to investigate prostate cancer. During surgery, prostate gland tissue is taken out with a biopsy needle through prostate biopsy in order to test the presence of cancer. Growing incidence of prostate cancer and rising technological development is the major factor driving the growth of this market. Furthermore, increasing research and development activities is set to further enhance the overall market demand for Prostate Biopsy Market for the period 2021-2026.Key Takeaways
Geographically, in 2020, North America dominated the Prostate Biopsy Market owing to availability of advanced biopsy devices and awareness among the people about disease.
Growing incidence of prostate cancer and rising technological development are likely to aid in the market growth of the Prostate Biopsy.
Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Prostate Biopsy Market report.
High cost associated with prostate biopsy is set to create hurdles for the Prostate Biopsy Market.
Request for Sample of the Report @ [FURL]https://www.industryarc.com/pdfdownload.php?id=507068[/FURL]
Prostate Biopsy Segment Analysis – By Geography
North America dominated the Prostate Biopsy Market with major share of 40% in 2020. This is owing to availability of advanced biopsy devices and awareness among the people about disease. According to American Cancer Society, about 191,930 men in U.S. are diagnosed with prostate cancer that increases the treatment of prostate biopsy and are increasing the growth of this market.
Prostate Biopsy Market Drivers
Growing Incidence of Prostate Cancer
Rising Technological Development
Prostate Biopsy Market Landscape
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Prostate Biopsy Market. Prostate Biopsy top 10 companies include, Koninklijke Philips N.V., Eigen, 3D Biopsy Inc., BIOBOT SURGICAL PTE LTD, Cook, Boston Scientific Corporation, STERIS LAB S.r.l, C. R. Bard, Inc., and Thermo Fisher Scientific Inc.
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.